Leiomyosarcomas (LMS) of the spermatic cord are exceedingly rare tumours. Radical inguinal orchiectomy and high ligation of the cord is the standard primary procedure. The extent of soft tissue excision required, including margins, and the precise role of adjuvant radiotherapy (RT), however, remains unclear. A 58-year-old male underwent excision of a large inguinoscrotal mass and orchiectomy. Histological examination revealed the mass to be a LMS of the spermatic cord with the tumour extending to one of the resection margins. Further surgery was nevertheless withheld for fear of creating a significant anatomical defect and hence the patient was referred for radiation therapy. He developed locoregional recurrence 2.5 years later which necessitated radical excision of soft tissues in the lower–anterior abdominal wall and inguinal region, and reconstruction using a tensor fascia lata flap. This report emphasizes the need for primary radical surgery until negative histological margins are achieved even if it involves sacrificing some adjacent normal anatomy. If margins are positive after primary surgery, re-excision should be the rule rather than the exception. Adjuvant RT, though useful, should not be considered as a substitute for complete surgical clearance. To the authors’ knowledge, this is the first report in medical literature of a case of spermatic cord LMS recurring after surgery and RT, requiring further radical surgery. The pathophysiology and the management of this complex and rare tumour are also reviewed.
European Journal of Plastic Surgery – Springer Journals
Published: May 1, 2004
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera